Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology

Clinical Biochemistry

Volumn 44, Issue 1, 2011, Pages 54-65

  Peters, Frank T ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Doping; Identification; Liquid chromatography; Mass spectrometry; Matrix effect; Quantification; Screening; Toxicology

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALKALOID; AMPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABINOID; CHLORPHENIRAMINE; COCAINE; CODEINE; DIHYDROCODEINE; DIURETIC AGENT; ETHYLMORPHINE; GLUCURONIDE; HYDROMORPHONE; ION; KETAMINE; MIDAZOLAM; MORPHINE; MORPHINE 6 ACETATE; NOSCAPINE; OPIATE; ORGANOPHOSPHATE; OXYCODONE; PAPAVERINE; PESTICIDE; PHENCYCLIDINE; RITALINIC ACID; STEROID; UNINDEXED DRUG; XENOBIOTIC AGENT;

ANALYSIS; CLINICAL EVALUATION; DOPING; DRUG IDENTIFICATION; ELECTROSPRAY; FORENSIC TOXICOLOGY; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PUBLISHING; REVIEW; SCREENING; TANDEM MASS SPECTROMETRY; TOXICOLOGY; VALIDATION PROCESS;

CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; FORENSIC TOXICOLOGY; HUMANS; TANDEM MASS SPECTROMETRY;

EID: 78650864016     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.008     Document Type: Review

References (94)

1. Drummer O.H. Drug testing in oral fluid. ClinBiochemRev. 2006, 27:147-159.
2. Hoja H., Marquet P., Verneuil B., Lotfi H., Penicaut B., Lachatre G. Applications of liquid chromatography-mass spectrometry in analytical toxicology: a review. JAnalToxicol. 1997, 21:116-126.
3. Marquet P. Progress of LC-MS in clinical and forensic toxicology [review]. TherDrug Monit. 2002, 24:255-276.
4. Maurer H.H. Liquid chromatography-mass spectrometry in forensic and clinical toxicology [review]. JChromatogrB BiomedSciAppl. 1998, 713:3-25.
5. Maurer H.H. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control [review]. ClinChemLabMed. 2004, 42:1310-1324.
6. Maurer H.H. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology[review]. ClinBiochem. 2005, 38:310-318.
7. Maurer H.H. Advances in analytical toxicology: current role of liquid chromatography-mass spectrometry for drug quantification in blood and oral fluid [review]. Anal Bioanal Chem 2005, 381:110-118.
8. Polettini A. Systematic toxicological analysis of drugs and poisons in biosamples by hyphenated chromatographic and spectroscopic techniques[review]. JChromatogrB. 1999, 733:47-63.
9. Wood M., Laloup M., Samyn N., Mar Ramirez F.M., De Bruijn E.A., Maes R.A., et al. Recent applications of liquid chromatography-mass spectrometry in forensic science. JChromatogrA. 2006, 1130:3-15.
10. Gallardo E., Queiroz J.A. The role of alternative specimens in toxicological analysis. Biomed Chromatogr 2008, 22:795-821.
11. Kintz P. Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes. Anal Bioanal Chem 2007, 388:1467-1474.
12. Kraemer T., Paul L.D. Bioanalytical procedures for determination of drugs of abuse in blood. Anal Bioanal Chem 2007, 388:1415-1435.
13. Lillsunde P. Analytical techniques for drug detection in oral fluid. Ther Drug Monit 2008, 30:181-187.
14. Pil K., Verstraete A. Current developments in drug testing in oral fluid. Ther Drug Monit 2008, 30:196-202.
15. Skelton H., Dann L.M., Ong R.T., Hamilton T., Ilett K.F. Drug screening of patients who deliberately harm themselves admitted to the emergency department. TherDrug Monit. 1998, 20:98-103.
16. Wu A.H., McKay C., Broussard L.A., Hoffman R.S., Kwong T.C., Moyer T.P., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. ClinChem. 2003, 49:357-379.
17. Maurer H.H. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 2007, 388:1315-1325.
18. Mueller C.A., Weinmann W., Dresen S., Schreiber A., Gergov M. Development of a multi-target screening analysis for 301 drugs using a qtrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid CommunMass Spectrom. 2005, 19:1332-1338.
19. Dresen S., Gergov M., Politi L., Halter C., Weinmann W. Esi-ms/ms library of 1, 253 compounds for application in forensic and clinical toxicology. Anal Bioanal Chem 2009, 395:2521-2526.
20. Dresen S., Ferreiros N., Gnann H., Zimmermann R., Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q Trap (R) LC-MS/MS system and library searching. Anal Bioanal Chem 2010, 396:2425-2434.
21. Sauvage F.L., Saint-Marcoux F., Duretz B., Deporte D., Lachatre G., Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 2006, 52:1735-1742.
22. Sauvage F.L., Picard N., Saint-Marcoux F., Gaulier J.M., Lachatre G., Marquet P. General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints. J Sep Sci 2009, 32:3074-3083.
23. Picard N., Dridi D., Sauvage F.L., Boughattas N.A., Marquet P. General unknown screening procedure for the characterization of human drug metabolites: application to loratadine phase I metabolism. J Sep Sci 2009, 32:2209-2217.
24. Elliott S., Smith C. Investigation of the first deaths in the united kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J Anal Toxicol 2008, 32:172-177.
25. Liu H.C., Liu R.H., Ho H.O., Lin D.L. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens. Anal Chem 2009, 81:9002-9011.
26. Dulaurent S., Moesch C., Marquet P., Gaulier J.M., Lachatre G. Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry. Anal Bioanal Chem 2010, 396:2235-2249.
27. Ojanpera I., Pelander A., Laks S., Gergov M., Vuori E., Witt M. Application of accurate mass measurement to urine drug screening. J Anal Toxicol. 2005, 29:34-40.
28. Ojanpera S., Pelander A., Pelzing M., Krebs I., Vuori E., Ojanpera I. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2006, 20:1161-1167.
29. Pelander A., Ojanpera I., Laks S., Rasanen I., Vuori E. Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. Anal Chem 2003, 75:5710-5718.
30. Pelander A., Ristimaa J., Rasanen I., Vuori E., Ojanpera I. Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry. Ther Drug Monit 2008, 30:717-724.
31. Pelander A., Tyrkko E., Ojanpera I. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening. Rapid Commun Mass Spectrom 2009, 23:506-514.
32. Polettini A., Gottardo R., Pascali J.P., Tagliaro F. Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionization-time-of-flight mass spectrometry. Anal Chem 2008, 80:3050-3057.
33. Liotta E., Gottardo R., Bertaso A., Polettini A. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers. J Mass Spectrom 2010, 45:261-271.
34. European Union Commission decision 2002/657/ec. Off J Eur Communities. 2002, L 221:8-36.
35. Lee H.K., Ho C.S., Iu Y.P., Lai P.S., Shek C.C., Lo Y.C., et al. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Anal Chim Acta 2009, 649:80-90.
36. Concheiro M., de Castro A., Quintela O., Lopez-Rivadulla M., Cruz A. Determination of mdma, mda, mdea and mbdb in oral fluid using high performance liquid chromatography with native fluorescence detection. Forensic SciInt. 2005, 150:221-226.
37. Ferreiros Bouzas N., Dresen S., Munz B., Weinmann W. Determination of basic drugs of abuse in human serum by online extraction and LC-MS/MS. Anal Bioanal Chem 2009, 395:2499-2507.
38. Bjork M.K., Nielsen M.K., Markussen L.O., Klinke H.B., Linnet K. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2010, 396:2393-2401.
39. Concheiro M., de Castro A., Quintela O., Cruz A., Lopez-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2008, 391:2329-2338.
40. Badawi N., Simonsen K.W., Steentoft A., Bernhoft I.M., Linnet K. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clin Chem 2009, 55:2004-2018.
41. Eichhorst J.C., Etter M.L., Rousseaux N., Lehotay D.C. Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem 2009, 42:1531-1542.
42. Sergi M., Bafile E., Compagnone D., Curini R., D'Ascenzo G., Romolo F.S. Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS. Anal Bioanal Chem 2009, 393:709-718.
43. Tabernero M.J., Felli M.L., Bermejo A.M., Chiarotti M. Determination of ketamine and amphetamines in hair by LC-MS/MS. Anal Bioanal Chem 2009, 395:2547-2557.
44. Kelly T., Gray T.R., Huestis M.A. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3, 4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium. J Chromatogr B Analyt Technol Biomed Life Sci. 2008, 867:194-204.
45. Klys M., Rojek S., Kulikowska J., Bozek E., Scislowski M. Usefulness of multi-parameter opiates-amphetamines-cocainics analysis in hair of drug users for the evaluation of an abuse profile by means of LC-APCI-MS-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 854:299-307.
46. Miller E.I., Wylie F.M., Oliver J.S. Simultaneous detection and quantification of amphetamines, diazepam and its metabolites, cocaine and its metabolites, and opiates in hair by LC-ESI-MS-MS using a single extraction method. J Anal Toxicol 2008, 32:457-469.
47. Pichini S., Pujadas M., Marchei E., Pellegrini M., Fiz J., Pacifici R., et al. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "Hallucinogenic designer drugs" In urine of consumers. J Pharm Biomed Anal 2008, 47:335-342.
48. Bucelli F., Fratini A., Bavazzano P., Comodo N. Quantification of drugs of abuse and some stimulants in hair samples by liquid chromatography-electrospray ionization ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:3931-3936.
49. Concheiro M., De Castro A., Quintela O., Cruz A., Lopez-Rivadulla M. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. J Anal Toxicol 2007, 31:573-580.
50. Concheiro M., Simoes S.M., Quintela O., de Castro A., Dias M.J., Cruz A., et al. Fast LC-MS/MS method for the determination of amphetamine, methamphetamine, MDA, MDMA, MDEA, MBDB and PMA in urine. Forensic Sci Int 2007, 171:44-51.
51. Andersson M., Gustavsson E., Stephanson N., Beck O. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine and 3, 4-methylenedioxymethamphetamine in urine drug testing. J Chromatogr B Analyt Technol Biomed Life Sci. 2008, 861:22-28.
52. Hegstad S., Khiabani H.Z., Kristoffersen L., Kunoe N., Lobmaier P.P., Christophersen A.S. Drug screening of hair by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2008, 32:364-372.
53. Fritch D., Blum K., Nonnemacher S., Haggerty B.J., Sullivan M.P., Cone E.J. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2009, 33:569-577.
54. Feng J., Wang L., Dai I., Harmon T., Bernert J.T. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS. J Anal Toxicol 2007, 31:359-368.
55. Kala S.V., Harris S.E., Freijo T.D., Gerlich S. Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2008, 32:605-611.
56. Gray T.R., Shakleya D.M., Huestis M.A. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal Bioanal Chem 2009, 393:1977-1990.
57. Oiestad E.L., Johansen U., Christophersen A.S. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem 2007, 53:300-309.
58. Simoes S.S., Ajenjo A.C., Franco J.M., Vieira D.N., Dias M.J. Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid. Rapid Commun Mass Spectrom 2009, 23:1451-1460.
59. Taylor K., Elliott S. A validated hybrid quadrupole linear ion-trap LC-MS method for the analysis of morphine and morphine glucuronides applied to opiate deaths. Forensic Sci Int 2009, 187:34-41.
60. Shakleya D.M., Huestis M.A. Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2009, 393:1957-1965.
61. Ahsman M.J., van der Nagel B.C., Mathot R.A. Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2010, 24:969-976.
62. de Castro A., Concheiro M., Shakleya D.M., Huestis M.A. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J Anal Toxicol 2009, 33:243-252.
63. Svensson J.O., Andersson M., Gustavsson E., Beck O. Electrospray LC_MS method with solid-phase extraction for accurate determination of morphine-, codeine-, and ethylmorphine-glucuronides and 6-acetylmorphine in urine. J Anal Toxicol 2007, 31:81-86.
64. de Castro A., Concheiro M., Shakleya D.M., Huestis M.A. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:3065-3071.
65. Berg T., Lundanes E., Christophersen A.S., Strand D.H. Determination of opiates and cocaine in urine by high ph mobile phase reversed phase UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:421-432.
66. Gergov M., Nokua P., Vuori E., Ojanpera I. Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry. Forensic Sci Int 2009, 186:36-43.
67. Gustavsson E., Andersson M., Stephanson N., Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. J Mass Spectrom 2007, 42:881-889.
68. Huang D.K., Liu C., Huang M.K., Chien C.S. Simultaneous determination of morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in hair by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2009, 23:957-962.
69. Musshoff F., Lachenmeier K., Trafkowski J., Madea B., Nauck F., Stamer U. Determination of opioid analgesics in hair samples using liquid chromatography/tandem mass spectrometry and application to patients under palliative care. Ther Drug Monit 2007, 29:655-661.
70. Pistos C., Karampela S., Papoutsis I., Athanaselis S., Spiliopoulou C., Maravelias C. Investigation of the identification point system adaptation in cocaine, benzoylecgonine and ecgonine methyl ester using a single quadrupole mass spectrometer. Rapid Commun Mass Spectrom 2009, 23:3772-3780.
71. Marchi I., Schappler J., Veuthey J.L., Rudaz S. Development and validation of a liquid chromatography-atmospheric pressure photoionization-mass spectrometry method for the quantification of alprazolam, flunitrazepam, and their main metabolites in haemolysed blood. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:2275-2283.
72. del Mar Ramirez Fernandez M., Laloup M., Wood M., De Boeck G., Lopez-Rivadulla M., Wallemacq P., et al. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. J Anal Toxicol 2007, 31:497-504.
73. Ishida T., Kudo K., Hayashida M., Ikeda N. Rapid and quantitative screening method for 43 benzodiazepines and their metabolites, zolpidem and zopiclone in human plasma by liquid chromatography/mass spectrometry with a small particle column. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:2652-2657.
74. Murray G.J., Danaceau J.P. Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877:3857-3864.
75. Politi L., Morini L., Polettini A. A direct screening procedure for diuretics in human urine by liquid chromatography-tandem mass spectrometry with information dependent acquisition. Clin Chim Acta 2007, 386:46-52.
76. Mazzarino M., de la Torre X., Botre F. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS. Anal Bioanal Chem 2008, 392:681-698.
77. Georgakopoulos C.G., Vonaparti A., Stamou M., Kiousi P., Lyris E., Angelis Y.S., et al. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom 2007, 21:2439-2446.
78. Kristoffersen L., Oiestad E.L., Opdal M.S., Krogh M., Lundanes E., Christophersen A.S. Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhythmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 850:147-160.
79. Touber M.E., van Engelen M.C., Georgakopoulus C., van Rhijn J.A., Nielen M.W. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry. Anal Chim Acta 2007, 586:137-146.
80. Ferreiros N., Dresen S., Alonso R.M., Weinmann W. Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression. Ther Drug Monit 2007, 29:824-834.
81. de Castro A., Ramirez Fernandez Mdel M., Laloup M., Samyn N., De Boeck G., Wood M., et al. High-throughput on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of 14 antidepressants and their metabolites in plasma. J Chromatogr A. 2007, 1160:3-12.
82. Roman M., Kronstrand R., Lindstedt D., Josefsson M. Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS. J Anal Toxicol 2008, 32:147-155.
83. Inoue S., Saito T., Mase H., Suzuki Y., Takazawa K., Yamamoto I., et al. Rapid simultaneous determination for organophosphorus pesticides in human serum by LC-MS. J Pharm Biomed Anal 2007, 44:258-264.
84. Qiu P., Chen X., Lin L., Ai C. Simultaneous determination of five toxic alkaloids in body fluids by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008, 875:471-477.
85. Wohlfarth A., Weinmann W., Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem 2010, 396:2403-2414.
86. Identification criteria for qualitative assays. Incorporating chromatography and mass spectrometry. WADA Technical Document - TD2003IDCR: WADA - World Anti-Doping Agency 2003.
87. Sauvage F.L., Gaulier J.M., Lachatre G., Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin Chem 2008, 54:1519-1527.
88. Kuepper U., Musshoff F., Madea B. Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology. Rapid Commun Mass Spectrom 2008, 22:1965-1970.
89. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm Res. 2000, 17:1551-1557.
90. Saar E., Gerostamoulos D., Drummer O.H., Beyer J. Comparison of extraction efficiencies and LC-MS-MS matrix effects using LLE and SPE methods for 19 antipsychotics in human blood. Anal Bioanal Chem 2009, 393:727-734.
91. Marchi I., Rudaz S., Veuthey J.L. Sample preparation development and matrix effects evaluation for multianalyte determination in urine. J Pharm Biomed Anal 2009, 49:459-467.
92. Remane D., Wissenbach D.K., Meyer M.R., Maurer H.H. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures. Rapid Commun Mass Spectrom 2010, 24:859-867.
93. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res. 2007, 24:1962-1973.
94. Bateman K.P., Kellmann M., Muenster H., Papp R., Taylor L. Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer. J Am Soc Mass Spectrom 2009, 20:1441-1450.